403 related articles for article (PubMed ID: 28213070)
1. Selective A
Fathalla AM; Soliman AM; Moustafa AA
Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study.
Soliman AM; Fathalla AM; Moustafa AA
Neurosci Lett; 2016 Jun; 623():63-70. PubMed ID: 27132082
[TBL] [Abstract][Full Text] [Related]
3. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK
J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic effects of antagonizing adenosine A
Motawi TK; Sadik NAH; Hamed MA; Ali SA; Khalil WKB; Ahmed YR
Mol Cell Biochem; 2020 Feb; 465(1-2):89-102. PubMed ID: 31820278
[TBL] [Abstract][Full Text] [Related]
5. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A
Nunes ACL; Carmo M; Behrenswerth A; Canas PM; Agostinho P; Cunha RA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732120
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.
Fathalla AM; Soliman AM; Ali MH; Moustafa AA
Front Behav Neurosci; 2016; 10():35. PubMed ID: 26973484
[TBL] [Abstract][Full Text] [Related]
8. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
9. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
10. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
13. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
Sharma S; Kumar P; Deshmukh R
Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
[TBL] [Abstract][Full Text] [Related]
15. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease.
Barbiero JK; Ramos DC; Boschen S; Bassani T; Da Cunha C; Vital MABF
Behav Pharmacol; 2022 Dec; 33(8):513-526. PubMed ID: 36094044
[TBL] [Abstract][Full Text] [Related]
18. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
[TBL] [Abstract][Full Text] [Related]
19. Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.
Horst CH; Schlemmer F; de Aguiar Montenegro N; Domingues ACM; Ferreira GG; da Silva Ribeiro CY; de Andrade RR; Del Bel Guimarães E; Titze-de-Almeida SS; Titze-de-Almeida R
Neurochem Res; 2018 Nov; 43(11):2132-2140. PubMed ID: 30267378
[TBL] [Abstract][Full Text] [Related]
20. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
